Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- (-) Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- (-) Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 64 Results
How Can Payers Advance Patient-reported Measures in Oncology, and Why Should We Care?
A peer-reviewed study describes the current state of patient-reported measures and patient-reported performance measures in oncology, the barriers to implementation, and actionable recommendations…
National Pharmaceutical Council Names Dr. Robert Dubois as Interim President and CEO
As interim president and CEO, Dr. Robert Dubois plans to focus on two priorities: continuing to leverage NPC's ongoing evidence-based research, partnerships and education, and preparing for future…
Building on NPC’s Commitment to Sound Health Policy Research and Evidence-based Dialogue
As the interim leader of NPC, Dr. Robert Dubois is focused on two priorities: continuing to leverage NPC's evidence-based research, partnerships, and education, and preparing for future policy…
NPC Comments on CMS Best Price and Barriers to Value-Based Arrangements
NPC outlines how Medicaid Best Price poses a barrier to implementing value-based arrangements and hinders innovation in payment and delivery systems, which can make it difficult for patients to…
A Path of Her Own: Salama Freed, 2020-22 NPC/Duke-Margolis Health Policy Fellow
Salama Freed, PhD, has always wanted to learn about the inner-world of health policy – who shapes it, what drives it and how it gets done. She believes that her path to this experience is through the…
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
Dr. Salama Freed has been named NPC/Duke-Margolis Health Policy Fellow for 2020-22.
National Pharmaceutical Council 2019 Annual Report
NPC's 2019 annual report outlines how the organization is driving discussions on some of the most complex topics in health care policy.
Do Patient Preferences Align with Value Frameworks? A Discrete-Choice Experiment of Patients with Breast Cancer
The study assessed patient preferences for aspects of breast-cancer treatments to evaluate the usual assumptions in scoring rubrics for value frameworks.
Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair
NPC announced that Blasine Penkowski, MBA, Chief Strategic Customer Officer of Johnson & Johnson Health Care Systems Inc., has been elected Chair of NPC’s Board of Directors for 2019-2020.
National Pharmaceutical Council 2018 Annual Report
2018 marked NPC’s 65th anniversary as a leader in health research and policy.
National Pharmaceutical Council 2018 Annual Report
National Pharmaceutical Council's 2018 Annual Report detailed our 65th anniversary as a leader in health policy research, celebrating a continued focus on strong research to drive conversations on…
Celgene EVP Richard Bagger Elected National Pharmaceutical Council Board Chair
The NPC Board of Directors has named Celgene EVP Richard Bagger as Chairman for 2018-19.
Bringing Patient-Centeredness to Quality Measurement in Health Care
Quality measures can help payers to reward better care, providers to take action to improve care, and patients to make informed decisions about where to seek care. Often, quality measures are focused…
Social Determinants of Health May Be Key to Value-based Care
There is growing recognition that improving access to care and patient health, including access to medications, requires focus on social, economic and environmental factors. At its upcoming…
Evaluation of Person-level Heterogeneity of Treatment Effects in Published Multiperson N-of-1 Studies: Systematic Review and Reanalysis
To understand when and how individual treatment effects are examined, conducted and reported, this study evaluated existing multiperson N-of-1 studies, which can identify whether an intervention is…
National Pharmaceutical Council 2017 Annual Report
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that…
Including the Patient’s Perspective in Valuing Treatments for Arthritis
NPC President Dan Leonard sat down for a Q&A session with Sandie Preiss, Vice President for Advocacy and Access at the Arthritis Foundation, to discuss how the value of treatments for arthritis…
National Pharmaceutical Council 2016 Annual Report
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that…
A Dynamic Approach to Consumer Cost-Sharing for Prescription Drugs
The level of consumer cost-sharing for higher cost medication should be aligned with the clinical value – not solely the price – when lower cost alternatives do not produce the desired patient…